Zydus seeks DCGI approval to undertake clinical trials for monoclonal antibodies cocktail
Mumbai, May 27 : Pharma major Zydus Cadila Today said that its biological therapy ZRC-3308, a cocktail of two SARS-CoV-2-neutralizing monoclonal antibodies (mAbs) can emerge as one of the main treatments for mild COVID-19.SARS-CoV-2 spike…